A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16818697

Clin. Cancer Res. 2006 Jul 1 12 13 3993-6

Download in:

View as

Triples

General Info

PMID
16818697